Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
-$0.23 today
- Market cap
- $685.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
Volume 0.59M
Average 0.42M
DCTH Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Delcath Systems, Inc.NASDAQ: DCTH
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $570K (cash outflow) rose 307.1% year over year, ahead of the +188.2% change in trailing-twelve-month capital expenditures. Sequentially, it rose 3.6% from the prior quarter. Over 3 fiscal years it compounded at +94.9% a year.
Context
- Capital expenditures amounted to 1.8% of revenue in FY2025, up 0.3 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +307.1% holds above the trailing-twelve-month pace of +188.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.55M) USD
- Year-over-year change
- -176.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.55M) | -176.7% |
| FY2024 | 2024-12-31 | (559K) | -863.8% |
| FY2023 | 2023-12-31 | (58K) | +72.2% |
| FY2022 | 2022-12-31 | (209K) | -46.2% |
| FY2021 | 2021-12-31 | (143K) | — |
Capital Expenditures vs competitors
How DCTH compares with its peers on the latest reported figures
- DCTH's LTM Mar 2026 capital expenditures of $1.98M is the 3rd largest of the 4 companies compared; the peer median is $14.95M.
- Its year-over-year change of +188.2% is the highest of 4, against a peer median of -70.1%.
- Capital expenditures amounts to 2.2% of revenue for DCTH, versus a peer median of 3.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21.19M | -49.2% | +7.7% | 3.1% | |
| LTM Mar 2026 | $14.95M | -70.1% | +248.2% | 2419.3% | |
| LTM Mar 2026 | $1.98M | +188.2% | +94.9% | 2.2% | |
| LTM Mar 2026 | $305K | -70.5% | +5.3% | 0.7% | |
| Peer median (excluding DCTH) | $14.95M | -70.1% | +7.7% | 3.1% | |
Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Depreciation & Amortization | 146K | 132K | 128K | 229K | 349K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.83M | 7.94M | 8.15M | 9.77M | 24.23M |
| Change in Working Capital | (5.76M) | 2.11M | (906K) | (15.52M) | (3.07M) |
| Accounts Receivables | 13K | (322K) | 125K | (10.65M) | (854K) |
| Inventory | (557K) | (587K) | (1.32M) | (3.61M) | (3.32M) |
| Accounts Payables | (1.14M) | 1.8M | (199K) | 479K | 4.77M |
| Other Working Capital | (4.08M) | 1.23M | 492K | (1.74M) | (3.66M) |
| Other Non-Cash Items | 831K | 1.37M | 9.05M | 13.23M | (1.7M) |
| Operating Cash Flow | (22.6M) | (24.95M) | (31.25M) | (18.68M) | 22.52M |
| Capital Expenditures | (143K) | (209K) | (58K) | (559K) | (1.55M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (19.65M) | (52.45M) | (93.22M) |
| Sales of Investments | 0 | 0 | 0 | 52.03M | 68.17M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (143K) | (209K) | (19.71M) | (981K) | (26.59M) |
| Debt Repayment | 14.44M | (714K) | (6.31M) | (10.61M) | 0 |
| Common Stock Issued | 3.92M | 10.86M | 23.08M | 7.02M | 21.05M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.46M | 0 | 35.01M | 43M | 0 |
| Financing Cash Flow | 20.82M | 10.14M | 51.78M | 39.41M | 15.05M |
| Effect of Forex Changes | 122K | (115K) | 56K | (32K) | 68K |
| Net Change in Cash | (1.8M) | (15.13M) | 874K | 19.72M | 11.04M |
| Free Cash Flow | (22.75M) | (25.16M) | (31.31M) | (19.24M) | 20.97M |
Delcath Systems, Inc.
NASDAQ:DCTH
Intrinsic Alpha fair value
Locked
Current Price
$19.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.